TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer

The aim of this study was to determine an optimal workflow to detect TP53 mutations in baseline and longitudinal serum cell free DNA (cfDNA) from high-grade serous ovarian carcinomas (HGSOC) patients and to define whether TP53 mutations are suitable as biomarker for disease. TP53 was investigated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitale, Silvia R., Groenendijk, Floris H., van Marion, Ronald, Beaufort, Corine M., Helmijr, Jean C., Jan Dubbink, Hendrikus, N. M. Dinjens, Winand, Ewing-Graham, Patricia C., Smolders, Ramon, van Doorn, Helena C., Boere, Ingrid A., Berns, Els M. J. J., Helleman, Jozien, Jansen, Maurice P. H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175353/
https://www.ncbi.nlm.nih.gov/pubmed/32156073
http://dx.doi.org/10.3390/biom10030415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175353/
https://www.ncbi.nlm.nih.gov/pubmed/32156073
http://dx.doi.org/10.3390/biom10030415

Ejemplares similares